Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome
- PMID: 15724016
- DOI: 10.1001/archderm.141.2.199
Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome
Abstract
Objective: To investigate the clinical features of the multiple cutaneous and uterine leiomyomatosis (MCUL) syndrome, including the hereditary leiomyomatosis and renal cell cancer syndrome.
Design: A case series of patients with multiple skin leiomyomas solicited via a circular letter to dermatologists.
Setting: Research institute.
Patients: A total of 108 affected individuals, including 46 probands and 62 affected relatives.
Main outcome measures: The proportion of probands with underlying fumarate hydratase (FH) mutations, the penetrance of FH mutations, and clinicopathologic features of MCUL.
Results: Forty-one (89%) of 46 probands with multiple skin leiomyomas had evidence of germline FH mutations, which were highly penetrant. All 26 male mutation carriers had skin leiomyomas. Of 67 women with FH mutations, 46 (69%) had both skin and uterine leiomyomas; 10 (15%) had only skin leiomyomas; 5 (7%) had only uterine leiomyomas; and 6 (9%) were clinically unaffected. Patients presented with skin leiomyomas at a mean age of 24 years and had a mean of 25 lesions. Forty-one individuals (89%) reported painful lesions, particularly in response to cold or trauma. Fibroids were histologically unremarkable, highly symptomatic, and associated with a high risk of early hysterectomy. One individual had a very aggressive collecting duct renal cancer. The G354R FH mutation predisposed patients to uterine fibroids without skin leiomyomas (P = .03). Many patients with skin leiomyomas had not previously presented for medical attention. Fibroids were rarely recognized as cases of MCUL.
Conclusions: Highly penetrant FH mutations underlie MCUL. Increased clinical awareness is important because of the associated risk of severe uterine fibroids and, in some cases, aggressive renal cancer.
Similar articles
-
Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.Br J Dermatol. 2005 Jul;153(1):11-7. doi: 10.1111/j.1365-2133.2005.06678.x. Br J Dermatol. 2005. PMID: 16029320 Review.
-
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency.Hum Mol Genet. 2003 Jun 1;12(11):1241-52. doi: 10.1093/hmg/ddg148. Hum Mol Genet. 2003. PMID: 12761039
-
Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients.Am J Surg Pathol. 2015 Nov;39(11):1529-39. doi: 10.1097/PAS.0000000000000520. Am J Surg Pathol. 2015. PMID: 26457356
-
Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.Clin Genet. 2011 Jan;79(1):49-59. doi: 10.1111/j.1399-0004.2010.01486.x. Clin Genet. 2011. PMID: 20618355
-
Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.Eur J Dermatol. 2009 Nov-Dec;19(6):545-51. doi: 10.1684/ejd.2009.0749. Epub 2009 Jul 10. Eur J Dermatol. 2009. PMID: 19939761 Review.
Cited by
-
Increased risk of cancer in patients with fumarate hydratase germline mutation.J Med Genet. 2006 Jun;43(6):523-6. doi: 10.1136/jmg.2005.036400. Epub 2005 Sep 9. J Med Genet. 2006. PMID: 16155190 Free PMC article.
-
Functional Characterization of FH Mutation c.557G>A Underlies Uterine Leiomyomas.Int J Mol Sci. 2022 Jan 27;23(3):1452. doi: 10.3390/ijms23031452. Int J Mol Sci. 2022. PMID: 35163394 Free PMC article.
-
Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance.Fam Cancer. 2012 Mar;11(1):123-9. doi: 10.1007/s10689-011-9491-5. Fam Cancer. 2012. PMID: 22086304 Free PMC article.
-
Hemangioblastoma in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: a phenotypic overlap between VHL and HLRCC Syndromes.Fam Cancer. 2019 Jan;18(1):91-95. doi: 10.1007/s10689-018-0081-7. Fam Cancer. 2019. PMID: 29619618
-
Studies on the Interaction of the Histone Demethylase KDM5B with Tricarboxylic Acid Cycle Intermediates.J Mol Biol. 2017 Sep 15;429(19):2895-2906. doi: 10.1016/j.jmb.2017.08.007. Epub 2017 Aug 18. J Mol Biol. 2017. PMID: 28827149 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous